Active Ingredient Voxelotor

Active Ingredient Details

What is the usage for Voxelotor?

This medication is used to treat sickle cell disease. People with sickle cell disease have a certain abnormal protein (hemoglobin S) in their red blood cells that makes the cells stiff and irregularly shaped (sickle- or crescent moon-shaped). Voxelotor works by decreasing hemoglobin S. This effect may decrease symptoms such as tiredness, shortness of breath, and attacks of pain (sickle cell crisis).

How many products in the NDC database contain Voxelotor?

The NDC database has 12 products with the active ingredient Voxelotor. The following table lists all the products that have this active ingredient.

NDC Products with Voxelotor

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
11014-0463Proprietary Name: VoxelotorTablet, Film CoatedCatalent Pharma Solutions, LlcACTIVE
57572-0726Proprietary Name: VoxelotorPowderEsteve Quimica SaACTIVE
58032-1029Proprietary Name: Voxelotor Adipic Acid Co-crystalPowderNeuland Laboratories LimitedACTIVE
58032-1030Proprietary Name: Voxelotor Form-iPowderNeuland Laboratories LimitedACTIVE
59116-5720Proprietary Name: VoxelotorPowderCambrex Charles City, IncACTIVE
66406-0301Proprietary Name: VoxelotorTablet, Film CoatedPatheon Inc.ACTIVE
66406-0333Proprietary Name: VoxelotorTablet, For SuspensionPatheon Inc.ACTIVE
66406-0442Proprietary Name: VoxelotorTablet, Film CoatedPatheon Inc.ACTIVE
72640-027Proprietary Name: VoxelotorPowderMsn Life Sciences Private LimitedACTIVE
72786-101Proprietary Name: Oxbryta VoxelotorTablet, Film CoatedOralGlobal Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.ACTIVE
72786-102Proprietary Name: Oxbryta VoxelotorTablet, Film CoatedOralGlobal Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.ACTIVE
72786-111Proprietary Name: Oxbryta VoxelotorTablet, For SuspensionOralGlobal Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.ACTIVE
<